Global Albumin (as Excipient) Market Growth 2022-2028
As the global economy mends, the 2021 growth of Albumin (as Excipient) will have significant change from previous year. According to our latest study, the global Albumin (as Excipient) market size is USD million in 2022 from USD 4246 million in 2021, with a change of % between 2021 and 2022. The global Albumin (as Excipient) market size will reach USD 6524 million in 2028, growing at a CAGR of 6.3% over the analysis period.
The United States Albumin (as Excipient) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Albumin (as Excipient) market, reaching US$ million by the year 2028. As for the Europe Albumin (as Excipient) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Albumin (as Excipient) players cover CSL, Grifols, Takeda, and Octapharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Albumin (as Excipient) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Human Serum Albumin
Recombinant Albumin
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Cell Culture Media
Medical Supplements
Therapeutics
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
CSL
Grifols
Takeda
Octapharma
Hualan Bio
CBPO
Shanghai RAAS
Kedrion
LFB Group
Albumedix
Biotest
Merck
Ventria (InVitria)
HiMedia
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Albumin (as Excipient) Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Albumin (as Excipient) by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Albumin (as Excipient) by Country/Region, 2017, 2022 & 2028
2.2 Albumin (as Excipient) Segment by Type
2.2.1 Human Serum Albumin
2.2.2 Recombinant Albumin
2.3 Albumin (as Excipient) Sales by Type
2.3.1 Global Albumin (as Excipient) Sales Market Share by Type (2017-2022)
2.3.2 Global Albumin (as Excipient) Revenue and Market Share by Type (2017-2022)
2.3.3 Global Albumin (as Excipient) Sale Price by Type (2017-2022)
2.4 Albumin (as Excipient) Segment by Application
2.4.1 Cell Culture Media
2.4.2 Medical Supplements
2.4.3 Therapeutics
2.5 Albumin (as Excipient) Sales by Application
2.5.1 Global Albumin (as Excipient) Sale Market Share by Application (2017-2022)
2.5.2 Global Albumin (as Excipient) Revenue and Market Share by Application (2017-2022)
2.5.3 Global Albumin (as Excipient) Sale Price by Application (2017-2022)
3 Global Albumin (as Excipient) by Company
3.1 Global Albumin (as Excipient) Breakdown Data by Company
3.1.1 Global Albumin (as Excipient) Annual Sales by Company (2020-2022)
3.1.2 Global Albumin (as Excipient) Sales Market Share by Company (2020-2022)
3.2 Global Albumin (as Excipient) Annual Revenue by Company (2020-2022)
3.2.1 Global Albumin (as Excipient) Revenue by Company (2020-2022)
3.2.2 Global Albumin (as Excipient) Revenue Market Share by Company (2020-2022)
3.3 Global Albumin (as Excipient) Sale Price by Company
3.4 Key Manufacturers Albumin (as Excipient) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Albumin (as Excipient) Product Location Distribution
3.4.2 Players Albumin (as Excipient) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Albumin (as Excipient) by Geographic Region
4.1 World Historic Albumin (as Excipient) Market Size by Geographic Region (2017-2022)
4.1.1 Global Albumin (as Excipient) Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Albumin (as Excipient) Annual Revenue by Geographic Region
4.2 World Historic Albumin (as Excipient) Market Size by Country/Region (2017-2022)
4.2.1 Global Albumin (as Excipient) Annual Sales by Country/Region (2017-2022)
4.2.2 Global Albumin (as Excipient) Annual Revenue by Country/Region
4.3 Americas Albumin (as Excipient) Sales Growth
4.4 APAC Albumin (as Excipient) Sales Growth
4.5 Europe Albumin (as Excipient) Sales Growth
4.6 Middle East & Africa Albumin (as Excipient) Sales Growth
5 Americas
5.1 Americas Albumin (as Excipient) Sales by Country
5.1.1 Americas Albumin (as Excipient) Sales by Country (2017-2022)
5.1.2 Americas Albumin (as Excipient) Revenue by Country (2017-2022)
5.2 Americas Albumin (as Excipient) Sales by Type
5.3 Americas Albumin (as Excipient) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Albumin (as Excipient) Sales by Region
6.1.1 APAC Albumin (as Excipient) Sales by Region (2017-2022)
6.1.2 APAC Albumin (as Excipient) Revenue by Region (2017-2022)
6.2 APAC Albumin (as Excipient) Sales by Type
6.3 APAC Albumin (as Excipient) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Albumin (as Excipient) by Country
7.1.1 Europe Albumin (as Excipient) Sales by Country (2017-2022)
7.1.2 Europe Albumin (as Excipient) Revenue by Country (2017-2022)
7.2 Europe Albumin (as Excipient) Sales by Type
7.3 Europe Albumin (as Excipient) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Albumin (as Excipient) by Country
8.1.1 Middle East & Africa Albumin (as Excipient) Sales by Country (2017-2022)
8.1.2 Middle East & Africa Albumin (as Excipient) Revenue by Country (2017-2022)
8.2 Middle East & Africa Albumin (as Excipient) Sales by Type
8.3 Middle East & Africa Albumin (as Excipient) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Albumin (as Excipient)
10.3 Manufacturing Process Analysis of Albumin (as Excipient)
10.4 Industry Chain Structure of Albumin (as Excipient)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Albumin (as Excipient) Distributors
11.3 Albumin (as Excipient) Customer
12 World Forecast Review for Albumin (as Excipient) by Geographic Region
12.1 Global Albumin (as Excipient) Market Size Forecast by Region
12.1.1 Global Albumin (as Excipient) Forecast by Region (2023-2028)
12.1.2 Global Albumin (as Excipient) Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Albumin (as Excipient) Forecast by Type
12.7 Global Albumin (as Excipient) Forecast by Application
13 Key Players Analysis
13.1 CSL
13.1.1 CSL Company Information
13.1.2 CSL Albumin (as Excipient) Product Offered
13.1.3 CSL Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 CSL Main Business Overview
13.1.5 CSL Latest Developments
13.2 Grifols
13.2.1 Grifols Company Information
13.2.2 Grifols Albumin (as Excipient) Product Offered
13.2.3 Grifols Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Grifols Main Business Overview
13.2.5 Grifols Latest Developments
13.3 Takeda
13.3.1 Takeda Company Information
13.3.2 Takeda Albumin (as Excipient) Product Offered
13.3.3 Takeda Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Takeda Main Business Overview
13.3.5 Takeda Latest Developments
13.4 Octapharma
13.4.1 Octapharma Company Information
13.4.2 Octapharma Albumin (as Excipient) Product Offered
13.4.3 Octapharma Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Octapharma Main Business Overview
13.4.5 Octapharma Latest Developments
13.5 Hualan Bio
13.5.1 Hualan Bio Company Information
13.5.2 Hualan Bio Albumin (as Excipient) Product Offered
13.5.3 Hualan Bio Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Hualan Bio Main Business Overview
13.5.5 Hualan Bio Latest Developments
13.6 CBPO
13.6.1 CBPO Company Information
13.6.2 CBPO Albumin (as Excipient) Product Offered
13.6.3 CBPO Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 CBPO Main Business Overview
13.6.5 CBPO Latest Developments
13.7 Shanghai RAAS
13.7.1 Shanghai RAAS Company Information
13.7.2 Shanghai RAAS Albumin (as Excipient) Product Offered
13.7.3 Shanghai RAAS Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Shanghai RAAS Main Business Overview
13.7.5 Shanghai RAAS Latest Developments
13.8 Kedrion
13.8.1 Kedrion Company Information
13.8.2 Kedrion Albumin (as Excipient) Product Offered
13.8.3 Kedrion Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Kedrion Main Business Overview
13.8.5 Kedrion Latest Developments
13.9 LFB Group
13.9.1 LFB Group Company Information
13.9.2 LFB Group Albumin (as Excipient) Product Offered
13.9.3 LFB Group Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 LFB Group Main Business Overview
13.9.5 LFB Group Latest Developments
13.10 Albumedix
13.10.1 Albumedix Company Information
13.10.2 Albumedix Albumin (as Excipient) Product Offered
13.10.3 Albumedix Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Albumedix Main Business Overview
13.10.5 Albumedix Latest Developments
13.11 Biotest
13.11.1 Biotest Company Information
13.11.2 Biotest Albumin (as Excipient) Product Offered
13.11.3 Biotest Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Biotest Main Business Overview
13.11.5 Biotest Latest Developments
13.12 Merck
13.12.1 Merck Company Information
13.12.2 Merck Albumin (as Excipient) Product Offered
13.12.3 Merck Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Merck Main Business Overview
13.12.5 Merck Latest Developments
13.13 Ventria (InVitria)
13.13.1 Ventria (InVitria) Company Information
13.13.2 Ventria (InVitria) Albumin (as Excipient) Product Offered
13.13.3 Ventria (InVitria) Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Ventria (InVitria) Main Business Overview
13.13.5 Ventria (InVitria) Latest Developments
13.14 HiMedia
13.14.1 HiMedia Company Information
13.14.2 HiMedia Albumin (as Excipient) Product Offered
13.14.3 HiMedia Albumin (as Excipient) Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 HiMedia Main Business Overview
13.14.5 HiMedia Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Albumin (as Excipient) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Albumin (as Excipient) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Human Serum Albumin
Table 4. Major Players of Recombinant Albumin
Table 5. Global Albumin (as Excipient) Sales by Type (2017-2022) & (MT)
Table 6. Global Albumin (as Excipient) Sales Market Share by Type (2017-2022)
Table 7. Global Albumin (as Excipient) Revenue by Type (2017-2022) & ($ million)
Table 8. Global Albumin (as Excipient) Revenue Market Share by Type (2017-2022)
Table 9. Global Albumin (as Excipient) Sale Price by Type (2017-2022) & (USD/Kg)
Table 10. Global Albumin (as Excipient) Sales by Application (2017-2022) & (MT)
Table 11. Global Albumin (as Excipient) Sales Market Share by Application (2017-2022)
Table 12. Global Albumin (as Excipient) Revenue by Application (2017-2022)
Table 13. Global Albumin (as Excipient) Revenue Market Share by Application (2017-2022)
Table 14. Global Albumin (as Excipient) Sale Price by Application (2017-2022) & (USD/Kg)
Table 15. Global Albumin (as Excipient) Sales by Company (2020-2022) & (MT)
Table 16. Global Albumin (as Excipient) Sales Market Share by Company (2020-2022)
Table 17. Global Albumin (as Excipient) Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Albumin (as Excipient) Revenue Market Share by Company (2020-2022)
Table 19. Global Albumin (as Excipient) Sale Price by Company (2020-2022) & (USD/Kg)
Table 20. Key Manufacturers Albumin (as Excipient) Producing Area Distribution and Sales Area
Table 21. Players Albumin (as Excipient) Products Offered
Table 22. Albumin (as Excipient) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Albumin (as Excipient) Sales by Geographic Region (2017-2022) & (MT)
Table 26. Global Albumin (as Excipient) Sales Market Share Geographic Region (2017-2022)
Table 27. Global Albumin (as Excipient) Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Albumin (as Excipient) Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Albumin (as Excipient) Sales by Country/Region (2017-2022) & (MT)
Table 30. Global Albumin (as Excipient) Sales Market Share by Country/Region (2017-2022)
Table 31. Global Albumin (as Excipient) Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Albumin (as Excipient) Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Albumin (as Excipient) Sales by Country (2017-2022) & (MT)
Table 34. Americas Albumin (as Excipient) Sales Market Share by Country (2017-2022)
Table 35. Americas Albumin (as Excipient) Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Albumin (as Excipient) Revenue Market Share by Country (2017-2022)
Table 37. Americas Albumin (as Excipient) Sales by Type (2017-2022) & (MT)
Table 38. Americas Albumin (as Excipient) Sales Market Share by Type (2017-2022)
Table 39. Americas Albumin (as Excipient) Sales by Application (2017-2022) & (MT)
Table 40. Americas Albumin (as Excipient) Sales Market Share by Application (2017-2022)
Table 41. APAC Albumin (as Excipient) Sales by Region (2017-2022) & (MT)
Table 42. APAC Albumin (as Excipient) Sales Market Share by Region (2017-2022)
Table 43. APAC Albumin (as Excipient) Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Albumin (as Excipient) Revenue Market Share by Region (2017-2022)
Table 45. APAC Albumin (as Excipient) Sales by Type (2017-2022) & (MT)
Table 46. APAC Albumin (as Excipient) Sales Market Share by Type (2017-2022)
Table 47. APAC Albumin (as Excipient) Sales by Application (2017-2022) & (MT)
Table 48. APAC Albumin (as Excipient) Sales Market Share by Application (2017-2022)
Table 49. Europe Albumin (as Excipient) Sales by Country (2017-2022) & (MT)
Table 50. Europe Albumin (as Excipient) Sales Market Share by Country (2017-2022)
Table 51. Europe Albumin (as Excipient) Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Albumin (as Excipient) Revenue Market Share by Country (2017-2022)
Table 53. Europe Albumin (as Excipient) Sales by Type (2017-2022) & (MT)
Table 54. Europe Albumin (as Excipient) Sales Market Share by Type (2017-2022)
Table 55. Europe Albumin (as Excipient) Sales by Application (2017-2022) & (MT)
Table 56. Europe Albumin (as Excipient) Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Albumin (as Excipient) Sales by Country (2017-2022) & (MT)
Table 58. Middle East & Africa Albumin (as Excipient) Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Albumin (as Excipient) Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Albumin (as Excipient) Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Albumin (as Excipient) Sales by Type (2017-2022) & (MT)
Table 62. Middle East & Africa Albumin (as Excipient) Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Albumin (as Excipient) Sales by Application (2017-2022) & (MT)
Table 64. Middle East & Africa Albumin (as Excipient) Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Albumin (as Excipient)
Table 66. Key Market Challenges & Risks of Albumin (as Excipient)
Table 67. Key Industry Trends of Albumin (as Excipient)
Table 68. Albumin (as Excipient) Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Albumin (as Excipient) Distributors List
Table 71. Albumin (as Excipient) Customer List
Table 72. Global Albumin (as Excipient) Sales Forecast by Region (2023-2028) & (MT)
Table 73. Global Albumin (as Excipient) Sales Market Forecast by Region
Table 74. Global Albumin (as Excipient) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Albumin (as Excipient) Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Albumin (as Excipient) Sales Forecast by Country (2023-2028) & (MT)
Table 77. Americas Albumin (as Excipient) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Albumin (as Excipient) Sales Forecast by Region (2023-2028) & (MT)
Table 79. APAC Albumin (as Excipient) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Albumin (as Excipient) Sales Forecast by Country (2023-2028) & (MT)
Table 81. Europe Albumin (as Excipient) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Albumin (as Excipient) Sales Forecast by Country (2023-2028) & (MT)
Table 83. Middle East & Africa Albumin (as Excipient) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Albumin (as Excipient) Sales Forecast by Type (2023-2028) & (MT)
Table 85. Global Albumin (as Excipient) Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Albumin (as Excipient) Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Albumin (as Excipient) Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Albumin (as Excipient) Sales Forecast by Application (2023-2028) & (MT)
Table 89. Global Albumin (as Excipient) Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Albumin (as Excipient) Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Albumin (as Excipient) Revenue Market Share Forecast by Application (2023-2028)
Table 92. CSL Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 93. CSL Albumin (as Excipient) Product Offered
Table 94. CSL Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 95. CSL Main Business
Table 96. CSL Latest Developments
Table 97. Grifols Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 98. Grifols Albumin (as Excipient) Product Offered
Table 99. Grifols Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 100. Grifols Main Business
Table 101. Grifols Latest Developments
Table 102. Takeda Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 103. Takeda Albumin (as Excipient) Product Offered
Table 104. Takeda Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 105. Takeda Main Business
Table 106. Takeda Latest Developments
Table 107. Octapharma Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 108. Octapharma Albumin (as Excipient) Product Offered
Table 109. Octapharma Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 110. Octapharma Main Business
Table 111. Octapharma Latest Developments
Table 112. Hualan Bio Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 113. Hualan Bio Albumin (as Excipient) Product Offered
Table 114. Hualan Bio Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 115. Hualan Bio Main Business
Table 116. Hualan Bio Latest Developments
Table 117. CBPO Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 118. CBPO Albumin (as Excipient) Product Offered
Table 119. CBPO Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 120. CBPO Main Business
Table 121. CBPO Latest Developments
Table 122. Shanghai RAAS Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 123. Shanghai RAAS Albumin (as Excipient) Product Offered
Table 124. Shanghai RAAS Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 125. Shanghai RAAS Main Business
Table 126. Shanghai RAAS Latest Developments
Table 127. Kedrion Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 128. Kedrion Albumin (as Excipient) Product Offered
Table 129. Kedrion Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 130. Kedrion Main Business
Table 131. Kedrion Latest Developments
Table 132. LFB Group Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 133. LFB Group Albumin (as Excipient) Product Offered
Table 134. LFB Group Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 135. LFB Group Main Business
Table 136. LFB Group Latest Developments
Table 137. Albumedix Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 138. Albumedix Albumin (as Excipient) Product Offered
Table 139. Albumedix Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 140. Albumedix Main Business
Table 141. Albumedix Latest Developments
Table 142. Biotest Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 143. Biotest Albumin (as Excipient) Product Offered
Table 144. Biotest Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 145. Biotest Main Business
Table 146. Biotest Latest Developments
Table 147. Merck Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 148. Merck Albumin (as Excipient) Product Offered
Table 149. Merck Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 150. Merck Main Business
Table 151. Merck Latest Developments
Table 152. Ventria (InVitria) Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 153. Ventria (InVitria) Albumin (as Excipient) Product Offered
Table 154. Ventria (InVitria) Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 155. Ventria (InVitria) Main Business
Table 156. Ventria (InVitria) Latest Developments
Table 157. HiMedia Basic Information, Albumin (as Excipient) Manufacturing Base, Sales Area and Its Competitors
Table 158. HiMedia Albumin (as Excipient) Product Offered
Table 159. HiMedia Albumin (as Excipient) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 160. HiMedia Main Business
Table 161. HiMedia Latest Developments
List of Figures
Figure 1. Picture of Albumin (as Excipient)
Figure 2. Albumin (as Excipient) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Albumin (as Excipient) Sales Growth Rate 2017-2028 (MT)
Figure 7. Global Albumin (as Excipient) Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Albumin (as Excipient) Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Human Serum Albumin
Figure 10. Product Picture of Recombinant Albumin
Figure 11. Global Albumin (as Excipient) Sales Market Share by Type in 2021
Figure 12. Global Albumin (as Excipient) Revenue Market Share by Type (2017-2022)
Figure 13. Albumin (as Excipient) Consumed in Cell Culture Media
Figure 14. Global Albumin (as Excipient) Market: Cell Culture Media (2017-2022) & (MT)
Figure 15. Albumin (as Excipient) Consumed in Medical Supplements
Figure 16. Global Albumin (as Excipient) Market: Medical Supplements (2017-2022) & (MT)
Figure 17. Albumin (as Excipient) Consumed in Therapeutics
Figure 18. Global Albumin (as Excipient) Market: Therapeutics (2017-2022) & (MT)
Figure 19. Global Albumin (as Excipient) Sales Market Share by Application (2017-2022)
Figure 20. Global Albumin (as Excipient) Revenue Market Share by Application in 2021
Figure 21. Albumin (as Excipient) Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Albumin (as Excipient) Revenue Market Share by Company in 2021
Figure 23. Global Albumin (as Excipient) Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Albumin (as Excipient) Revenue Market Share by Geographic Region in 2021
Figure 25. Global Albumin (as Excipient) Sales Market Share by Region (2017-2022)
Figure 26. Global Albumin (as Excipient) Revenue Market Share by Country/Region in 2021
Figure 27. Americas Albumin (as Excipient) Sales 2017-2022 (MT)
Figure 28. Americas Albumin (as Excipient) Revenue 2017-2022 ($ Millions)
Figure 29. APAC Albumin (as Excipient) Sales 2017-2022 (MT)
Figure 30. APAC Albumin (as Excipient) Revenue 2017-2022 ($ Millions)
Figure 31. Europe Albumin (as Excipient) Sales 2017-2022 (MT)
Figure 32. Europe Albumin (as Excipient) Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Albumin (as Excipient) Sales 2017-2022 (MT)
Figure 34. Middle East & Africa Albumin (as Excipient) Revenue 2017-2022 ($ Millions)
Figure 35. Americas Albumin (as Excipient) Sales Market Share by Country in 2021
Figure 36. Americas Albumin (as Excipient) Revenue Market Share by Country in 2021
Figure 37. United States Albumin (as Excipient) Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Albumin (as Excipient) Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Albumin (as Excipient) Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Albumin (as Excipient) Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Albumin (as Excipient) Sales Market Share by Region in 2021
Figure 42. APAC Albumin (as Excipient) Revenue Market Share by Regions in 2021
Figure 43. China Albumin (as Excipient) Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Albumin (as Excipient) Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Albumin (as Excipient) Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Albumin (as Excipient) Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Albumin (as Excipient) Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Albumin (as Excipient) Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Albumin (as Excipient) Sales Market Share by Country in 2021
Figure 50. Europe Albumin (as Excipient) Revenue Market Share by Country in 2021
Figure 51. Germany Albumin (as Excipient) Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Albumin (as Excipient) Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Albumin (as Excipient) Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Albumin (as Excipient) Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Albumin (as Excipient) Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Albumin (as Excipient) Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Albumin (as Excipient) Revenue Market Share by Country in 2021
Figure 58. Egypt Albumin (as Excipient) Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Albumin (as Excipient) Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Albumin (as Excipient) Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Albumin (as Excipient) Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Albumin (as Excipient) Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Albumin (as Excipient) in 2021
Figure 64. Manufacturing Process Analysis of Albumin (as Excipient)
Figure 65. Industry Chain Structure of Albumin (as Excipient)
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
